EGFR and neoplasm: With this important caveat, we observed that these three genes exhibited significant downregulation in tumor cells from EGFR-mutant patients (L858R/Exon19del/Exon20ins) compared with non-mutant counterparts (Figures 7A–F), though we cannot rule out that this expression pattern was influenced by the prior therapy.